Oct 31, 2024 / 10:00AM GMT
Presentation
Oct 31, 2024 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Christopher O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director
* Giles Platford
Takeda International Uk Branch - Director
=====================
Conference Call Participants
=====================
* Stephen Barker
Jefferies - Analyst
* Michael Nedelcovych
TD Cowen - Analyst
* Matsubara San
Nomura Securities Co. - Analyst
* Tony Ren
Macquarie Research - Analyst
* Miki Sogi
Bernstein - Analyst
* Editor
=====================
Christopher O'Reilly Takeda
Takeda Pharmaceutical Co Ltd
(OTCPK:TKPHF)
$
28.6
0 (0%)
Market Cap: 44.77 Bil
Enterprise Value: 71.99 Bil
PE Ratio: 23.21
PB Ratio: 0.98
GF Score: 78/100 Q2 2025 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Oct 31, 2024 / 10:00AM GMT
Release Date Price:
$27
(+1.16%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot